Johnson & Johnson

Johnson & Johnson is a top pharmaceutical company based in New Brunswick NJ, USA

Johnson & Johnson is a top pharmaceutical company based in New Brunswick NJ, USA.The company was founded in 1886.

Johnson & Johnson has embraced research and science - bringing innovative ideas, products and services to advance the health and well-being of people.

Johnson & Johnson has more than 250 companies located in 57 countries around the world.

Report: Partnering Deals and Alliances with Johnson & Johnson / Janssen

Johnson & Johnson is a top pharmaceutical company based in New Brunswick NJ, USA.

The company was founded in 1886.

Johnson & Johnson has embraced research and science - bringing innovative ideas, products and services to advance the health and well-being of people.

Johnson & Johnson has more than 250 companies located in 57 countries around the world.

The company has four businesses; all focused on advancing innovations that provide better options and outcomes, enabling healthier lives:

Consumer Healthcare – The Consumer segment includes a broad range of products used in the baby care, skin care, oral care, wound care and women’s health care fields, as well as nutritional and over-the-counter pharmaceutical products, and wellness and prevention platforms.

Medical devices & Diagnostics – The Medical Devices and Diagnostics segment produces a broad range of innovative products used primarily by health care professionals in the fields of orthopaedics, neurovascular, surgery, vision care, diabetes care, infection prevention, diagnostics, cardiovascular disease, sports medicine, and aesthetics. This segment is comprised of our Global Medical Solutions, Global Orthopaedics and Global Surgery Groups. 

Pharmaceuticals – The Pharmaceutical segment’s broad portfolio focuses on unmet medical needs across several therapeutic areas:

  • Cardiovascular & metabolism,
  •  Immunology,
  • Infectious diseases & vaccines,
  • Neuroscience & pain,
  • Oncology

Johnson & Johnson has an active licensing venture investment and acquisition group charged with analysing and managing all incoming opportunities. Johnson & Johnson has a long history of partnering, building numerous collaborative partnerships more

Johnson & Johnson announced over 176 partnering / licensing deals since 2005, with over 39 deals in 2012 alone. Analysis of the partnering deals shows a strong emphasis on partnerships in cardiovascular, cancer, followed by infectives, central nervous system, genitourinary and metabolic diseases more

Johnson & Johnson has also announced over 16 M&A deals since 2005, with the lead deals being the acquisition of Synthes, Crucell and Mentor more

Report: Partnering Deals and Alliances with Johnson & Johnson / Janssen

Examples of recent M&A deals announced by Johnson & Johnson can be viewed in Current Partnering's Johnson & Johnson / Janssen: M&A activity 2005-2013 M&A activity review article.

Our report provides more detailed insight into the details of each deal. See: Report: Partnering Deals and Alliances with Johnson & Johnson / Janssen

Available reports from Current Partnering

Report: Partnering Deals and Alliances with Johnson & Johnson / Janssen

Report: Partnering Deals and Alliances with Big Pharma

Available resources for deal coverage for Johnson & Johnson

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on Johnson & Johnson company profile, recent partnering, M&A and financing news and articles

Related

Report: Practical Guide to Finding Partners

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

Print Friendly, PDF & Email
cabannerad300x150new4gif
rauconbadgejpg
e80banner300x150animgif
cpbannerad300x150new1gif
e80banner300x150animgif
a1banner300x150animgif